Bottom line
PINK vs JEHSX: the short answer
PINK (Simplify Health Care ETF) and JEHSX (Health Sciences Trust) are both etfs.
But JEHSX is far broader, holding 173 positions to 54 for PINK, so beyond the top names it adds exposure PINK doesn't have.
PINK is cheaper at 0.51% vs 1.04% — a difference of $53 a year per $10,000 invested.
Over one year, PINK returned +24.1% vs +19.5% for JEHSX.
Updated Nov 19, 2026
PINK vs JEHSX side by side
| PINK | JEHSX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | Simplify Exchange Traded | John Hancock |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.51% | 1.04% |
| Annual cost per $10k | $51 | $104 |
| 10-yr cost on $10k (prospectus) | $641 | $1,282 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0.05% |
| 1-yr return | +24.1% | +19.5% |
| 5-yr return (annualized) | — | +4.2% |
| 10-yr return (annualized) | — | +8.7% |
| Best quarter | +15.6% | +23.6% |
| Worst quarter | −9.5% | −16.1% |
| Net assets (fund) | $358.6M | $251.3M |
| Number of holdings | 54 | 173 |
| Portfolio turnover | 171% | 68% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | PINK | JEHSX | Difference |
|---|---|---|---|
| 2025 | +24.1% | +19.5% | +4.6% |
| 2024 | +8.9% | +1.8% | +7.1% |
| 2023 | +3.8% | +4.3% | −0.5% |
| 2022 | −4.3% | −13.1% | +8.8% |
Source: Fund prospectus bar charts
Holdings overlap
12 of PINK's top 25 holdings also appear in JEHSX's top 25.
| Holding | PINK | JEHSX |
|---|---|---|
| Eli Lilly & Company | 5.91% | 14.30% |
| Unitedhealth Group Inc | 5.76% | 5.95% |
| Johnson & Johnson | 5.45% | 6.33% |
| Abbvie Inc | 4.52% | 5.28% |
| Thermo Fisher Scientific Inc | 3.23% | 2.67% |
| Gilead Sciences Inc | 2.87% | 2.95% |
| Elevance Health Inc | 2.73% | 1.63% |
| Danaher Corp | 2.28% | 1.51% |
| Amgen Inc | 2.12% | 1.90% |
| Cvs Health Corp | 2.01% | 0.98% |
| Cardinal Health Inc | 1.78% | 1.09% |
| Vertex Pharmaceuticals Inc | 1.45% | 2.38% |
Source: SEC Form N-PORT
PINK top 10
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Novo Nordisk A/s — 6.75%
- Eli Lilly & Company — 5.91%
- Unitedhealth Group Inc — 5.76%
- Warby Parker Inc — 5.46%
- Johnson & Johnson — 5.45%
- Jazz Pharmaceuticals Plc — 4.61%
- Abbvie Inc — 4.52%
- Biohaven Ltd — 4.32%
JEHSX top 10
- Eli Lilly and Company — 14.30%
- Johnson and Johnson — 6.33%
- UnitedHealth Group Incorporated — 5.95%
- AbbVie Inc. — 5.28%
- Merck and Co. Inc. — 4.21%
- Gilead Sciences Inc. — 2.95%
- Thermo Fisher Scientific Inc. — 2.67%
- Vertex Pharmaceuticals Incorporated — 2.38%
- Bristol-Myers Squibb Company — 2.22%
- Abbott Laboratories — 2.00%
FAQ
What is the difference between PINK and JEHSX?
Which is cheaper, PINK or JEHSX?
Should I own both PINK and JEHSX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.